Skip to content
MedsAcross

Manufacturer

Hepalink

Products listed
11
Molecules
2
Therapy areas
2

Hepalink is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 11 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
Hepalink USA Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Hepalink products through licensed channels, with the documents your regulator needs.

Haematology

7 presentations

Haematology overview
MedicineActive ingredientRegisterAvailability
Enoxaparin 100 mg/1 mL injectionSubcutaneousGeneric nameEnoxaparinUS FDAAvailable on request
Enoxaparin 120 mg/0.8 mL injectionSubcutaneousGeneric nameEnoxaparinUS FDAAvailable on request
Enoxaparin 150 mg/1 mL injectionSubcutaneousGeneric nameEnoxaparinUS FDAAvailable on request
Enoxaparin 30 mg/0.3 mL injectionSubcutaneousGeneric nameEnoxaparinUS FDAAvailable on request
Enoxaparin 40 mg/0.4 mL injectionSubcutaneousGeneric nameEnoxaparinUS FDAAvailable on request
Enoxaparin 60 mg/0.6 mL injectionSubcutaneousGeneric nameEnoxaparinUS FDAAvailable on request
Enoxaparin 80 mg/0.8 mL injectionSubcutaneousGeneric nameEnoxaparinUS FDAAvailable on request

Cardiology

4 presentations

Cardiology overview
MedicineActive ingredientRegisterAvailability
Heparin 1000 units/mL injectionIntravenous, subcutaneousGeneric nameHeparinUS FDAAvailable on request
Heparin 10000 units/mL injectionIntravenous, subcutaneousGeneric nameHeparinUS FDAAvailable on request
Heparin 20000 units/mL injectionIntravenous, subcutaneousGeneric nameHeparinUS FDAAvailable on request
Heparin 5000 units/mL injectionIntravenous, subcutaneousGeneric nameHeparinUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Hepalink

Send a request for any of these products. We confirm the licensed source, documents and lead time.